Metraipolis › archive › dc_d783d3e01aa4

Refractory Pembrolizumab-Induced Myocarditis-Myositis-Myasthenia Gravis Overlap Syndrome With Concurrent Hepatitis and Thyroiditis in Endometrial Carcinoma: A… — Europe PMC PMID:42261457

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/42261457
DOI
10.7759/cureus.110341
License (as archived)
solo-consultazione
Archived
2026-10-31T17:37:20.449Z
SHA-256 of the archived text
83ce9ecbfba3008eb78d8479587e15b26c6832a3e8d86100c5cb79598cdaeb78
Stable URL of this page
https://metraipolis.com/documento/dc_d783d3e01aa4

How to cite

Refractory Pembrolizumab-Induced Myocarditis-Myositis-Myasthenia Gravis Overlap Syndrome With Concurrent Hepatitis and Thyroiditis in Endometrial Carcinoma: A… — Europe PMC PMID:42261457 — Europe PMC (en), https://europepmc.org/article/MED/42261457 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_d783d3e01aa4 (Metraipolis archive dc_d783d3e01aa4, sha256 83ce9ecbfba3008eb78d8479587e15b26c6832a3e8d86100c5cb79598cdaeb78)
BibTeX
@misc{dcd783d3e01aa4,
  title = {Refractory Pembrolizumab-Induced Myocarditis-Myositis-Myasthenia Gravis Overlap Syndrome With Concurrent Hepatitis and Thyroiditis in Endometrial Carcinoma: A… — Europe PMC PMID:42261457},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/42261457},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_d783d3e01aa4; sha256 83ce9ecbfba3008eb78d8479587e15b26c6832a3e8d86100c5cb79598cdaeb78},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42261457. Agents can read the archived copy with the MCP tool read_document.